Why is Max Financial CLSA’s top pick in Life Insurance sector? 4 reasons are…

The insurance sector has been through a turmoil lately, coupled with regulatory crackdown. CLSA believes the insurance sector will continue to see a slowdown. Within the sector, it has chosen Max Financial Services as its top ‘Buy’ in the sector.

CLSA on Max Financial: regulatory overhang on sector continues

The brokerage house picked Max Financial, given the possible listing of Axis Max Life. Private insurers’ individual annualised premium equivalent grew 2% in February 2025 while for total it rose 9%. This was the slowest since March 2024. “In our view, volatility in equity market could have caused slowdown in Ulip sales (we await clarity),” said CLSA. Apart from the business slowdown, the key risk for the sector remains to be the regulatory area, such as regulatory suggestions on mis-selling, delays in the Insurance Amendment Bill, etc.

ALSO READContrarian Buy: CLSA sees 30% upside for IndusInd Bank

CLSA on Max Financial: Total sectoral APE growth intact at 9%

The private insurance companies’ total APE was up 9% YoY in Feb 2025 on a base of 24%. While the Individual APE growth for them was 2% YoY, with the individual number of policies (NOP) declining by 4% YoY in February 2025. “Our estimate of retail protection sum assured, indicates 44% YoY growth in January 2025 on a base of 45%. The strong momentum in protection has sustained,” said CLSA.

ALSO READBEL is Nifty’s top performer: Here’s what’s driving the surge

Performance of our coverage

Apart from Max Financial, the brokerage firm chose Axis Max Life as one of its top picks on value unlocking from the possible listing of Axis Max Life. The company is yet to list on exchanges. Axis Max Life’s total APE was up 8% YoY in Feb on a high base of 36%. “Recently, Indian court allowed reverse merger of an insurance company with its holding company, which sets a precedent for Max Financial,” CLSA said.

 » Read More

Related Articles

Zydus Lifesciences – Will it succeed in aggressively moving up the value chain?

By Amriteshwar Mathur Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus Lifesciences has made a foray in the higher margin orthopedic products segment with an acquisition of 85.6% stake in France-based Amplitude

Two chemical stocks indicating strength and reversal

By Kiran Jani The chemical sector, which has been on a downward trend for the past five months is finally showing signs of a recovery. With prices stabilising and the broader market improving, some stocks are showing potential for a turnaround. HEG and Graphite have formed potential reversal patterns, indicating possible opportunities for traders and

Three auto stocks potentially at bargain buying point

The market has been in a corrective phase for the seventh consecutive month, with many stocks taking a significant dip of 20-40%. After a period of stellar returns between 2020 and 2024, investor expectations were sky-high, but the recent downturn has led to many losing interest in the markets. While these dips have been challenging

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Zydus Lifesciences – Will it succeed in aggressively moving up the value chain?

By Amriteshwar Mathur Zydus Lifesciences is attempting to move up the value chain in the global pharma industry with its expanding focus on the medical technology segment. As part of the above strategy, Zydus Lifesciences has made a foray in the higher margin orthopedic products segment with an acquisition of 85.6% stake in France-based Amplitude

Two chemical stocks indicating strength and reversal

By Kiran Jani The chemical sector, which has been on a downward trend for the past five months is finally showing signs of a recovery. With prices stabilising and the broader market improving, some stocks are showing potential for a turnaround. HEG and Graphite have formed potential reversal patterns, indicating possible opportunities for traders and

Three auto stocks potentially at bargain buying point

The market has been in a corrective phase for the seventh consecutive month, with many stocks taking a significant dip of 20-40%. After a period of stellar returns between 2020 and 2024, investor expectations were sky-high, but the recent downturn has led to many losing interest in the markets. While these dips have been challenging

Is your FD really safe? Know insurance coverage for your deposits with IndusInd and other banks

IndusInd Bank is in the news this week as its stock crashed to a 52-week low (on March 11, 2025) due to an accounting error linked to forex derivative transactions. However, the stock recovered slightly the next day. This financial mess, which might not directly harm ordinary depositors, has once again drawn attention to bank

Baba Ramdev’s Patanjali Ayurved enters insurance sector with majority stake in Magma General Insurance

Baba Ramdev-owned Patanjali Ayurved has expanded its business footprint by acquiring a majority stake in Magma General Insurance. This strategic move marks Patanjali’s entry into the competitive general insurance sector, further diversifying its portfolio beyond its established Ayurvedic, wellness, and consumer goods offerings, reports CNBC TV18. Following the acquisition, Patanjali Ayurved will become the promoter